Lead cancer drug candidate, ST-001 nanoFenretinide, has received Institutional Review Board ("IRB") approval for its upcoming clinical trials for T-Cell Lymphomas.

Beginning in the second quarter of 2023, NIT will provide Actinium-225 in millicurie quantities, marking a significant step forward in cancer treatment

The Contract Manufacturing Agreement Will Provide the Clinical Supply of ST-001, SciTech's Lead Drug Candidate for Cancer

The collaboration between Lucem Health, Mayo Clinic Platform, and First Ascent Biomedical will reduce complexity while developing new, or enhancing existing, solutions that help clinicians make better decisions, diagnose earlier, improve efficiency, and serve patients better.

Next-Generation Cancer Diagnostics Market to Grow 22% Annually Through 2025

Presentations highlight significant new data for key oncology drug development programmes - USP7 small molecule inhibitors and ROR1 Protein: Drug Conjugates

Funding to Accelerate Commercialization of the Aurora-RT

Using a simple blood test for early cancer diagnosis and treatment monitoring

Using a simple blood test for early cancer diagnosis and treatment monitoring

Fastest Growth Anticipated in the Asia-Pacific Region

Inolife partners with the University of Ottawa/CHEO-RI to work on genetically-engineered viruses to treat cancers

There are now options other than standard chemotherapy - precision oncology is changing the face of cancer care. The future of cancer care is NOW.

At the summit, international participants from leading cancer centers discussed the application of Alpha DaRT to various cancer types.

Highlands Oncology Group Will Sponsor Bike Ride Benefiting The Cancer Challenge

Showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.

Showing the ability of Alpha DaRT to effectively and safely destroy solid tumors, Alpha Tau Medical raises more capital than planned.

Patrick Loughney's 70-700 Victory Ride Celebrates 5 Years in Remission, 70th Birthday; Highlights Importance of Fitness During Treatment

Dr. J. Thaddeus Beck, of Highlands Oncology Group, Appointed to Ove

Collaboration among Cancer Centers in Arkansas Helps to Place Patients in New Breast Cancer Clinical Trial

On September 27th, 2016 Highlands Oncology Group Will Host Free Prostate Cancer Screenings in Collaboration With The Arkansas Prostate Cancer Foundation

Highlands Oncology Group is Excited to Welcome Dr. Juan Lombeida to the Team

Highlands Oncology Group Proudly Congratulates Nurses on Achieving Certification in Oncology Nursing

Highlands Oncology Group Conducted the First Screening In Global Research Initiative

Highlands Oncology Group Collaborated on Study of Breast Cancer Recurrence

CMS Oncology Care Model attracts almost twice the expected number of physician group practices

Highlands Oncology Group Will Celebrate 20th Anniversary in June

Local Oncologist Presented Research On Breast Cancer Treatment In Miami

Highlands Oncology Group Connects Those Affected By Lymphedema With Support Group

Cancer Medical Review makes life easier for patients by introducing new online payment facilities. The leading hospital treats every form of urological issues through cutting-edge treatments.

Global Vision NGO in Thane organized a camp for cancer awareness and mammography screening to detect breast cancer on 11th Oct 2015.

Despite the risks, chemotherapy is administered in children who are fighting with cancer. Although it gives immediate and effective results, long term view of cancer treatment in children says something else .

Highlands Oncology Group (HOG) has been involved in a breakthrough trial studying the effects of a combination of two medications on the treatment of refractory metastatic pancreatic cancer.

June is national Men's Health/Cancer Awareness Month, and as the area's leading cancer research facility, Highlands Oncology Group (HOG), supports cancer awareness and overall health awareness in men.

Local pest control company gives a $500 grant to a Facebook fan to pay for cancer treatments.

The new Cancer Care Center places emphasis on a warm, welcoming environment for patients, families, and visitors.

Southern Ocean Medical Center to Sponsor Drive Thru Flu Shots.

Anaheim, CA 9/16/2011 - Dr. Daniel Jae Kim, along with the outstanding oncologists and hematologists from The Oncology Institute of Hope and Innovation, are celebrating 14 months of success at their Anaheim center.

Riverview Medical Center announce a new adult outpatient art therapy program called "New Impressions." designed for newly diagnosed patients to respond to their cancer experience.

An organizational system designed by a breast cancer survivor to help patients and their families navigate through the treatment process.

Nova Cells Institute has had great success with an experimental cancer treatment that uses mismatched donor granulocytes and umbilical cord stem cells to turn the immune system against cancer. It is inviting cancer patients to enroll in its program.

MediAngels, the world's first Global eHospital brings technology and top-class healthcare service delivery on a single platform. This Global eHospital has been founded by Dr. Arbinder Singal and Dr. Debraj Shome.

HCG launched the world's 1st Biograph m CT, an advanced technology of a High Definition PET CT scan which is the next level of integrated imaging.

Immunotherapy made a giant leap forward this weekend with the release of clinical trial results of BMS's ipilimumab. The results indicate that ipilimumab significantly improved the survival of patients with late stage melanoma.

A major advance from the usual medical tourism websites, Bestcancerhospitalindia.com - a new online portal offers a unique guide to the best cancer care facilities in India that offer world class quality of treatment and care at the lowest cost...

Cell Therapy Brings Refreshing Hope

Immune System Challenges Cancer
Cell Therapy Brings Refreshing Hope

Recent studies presented at ASCO and published in the International Journal of Gynecologic Cancer, evaluated the association between prediction of response to chemotherapy and progression-free interval and overall survival in ovarian cancer.

Precision Therapeutics, Inc. today announced that CEO Sean McDonald provided a company presentation at the J.P. Morgan 28th Annual Healthcare Conference, held at the Westin St. Francis Hotel in San Francisco, California, on Thursday, January 14, 2010

Hypnotists are going to use hypnosis techniques in cancer treatment to improve the quality of cancer therapies.